Back to home

    Sally A1C

    A1C

    Evaluation Score

    Overall rating on a scale of 0-10

    RiskReturn
    02.810
    Risk Level:
    Very High
    Recommendation:Avoid
    Evaluated:August 28, 2026 (v14)

    Dimension Breakdown

    Development Activity6.0
    Community Health1.5
    Tokenomics2.0
    Market & Use Case2.5
    Team & Governance2.5
    Security & Audits1.5

    AI Analysis

    Comprehensive evaluation of the token

    A1C (Sally A1C) is an AI metabolic-health agent token deployed on the Base network by Singapore-registered A1C PTE. LTD. While the project demonstrates active technical development with live platform tools (Sally Console, MCP server, and Hugging Face models), it presents severe structural and financial risks across all other dimensions. Tokenomics data is heavily contradictory across data providers, with circulating supply estimates swinging between 21 million and 75 million alongside unverified distribution schedules. The community presence is minimal with virtually no organic off-chain social presence or DAO governance. Furthermore, the team remains fully anonymous, no independent third-party smart contract audits exist, and market data reflects extreme liquidity fragmentation and micro-cap constraints. With no qualifying red-flag events affirmatively established but pervasive opacity and lack of security verification, the project represents an exceptionally high-risk profile.

    Development Activity

    Code updates and developer engagement

    RiskReturn
    06.010

    Community Support

    Social media presence and community engagement

    RiskReturn
    01.510

    Tokenomics

    Supply, distribution, and utility

    RiskReturn
    02.010

    Market & Use Case

    Value proposition and competitive landscape

    RiskReturn
    02.510

    Team & Governance

    Team background and project governance

    RiskReturn
    02.510

    Security & Audits

    Security history and audit status

    RiskReturn
    01.510

    About Sally A1C (A1C)

    A1C (Sally A1C) is an artificial intelligence token deployed on the Base blockchain, focused on metabolic health and chronic disease management. Developed by A1C PTE. LTD., a Singapore-registered corporate entity, the project provides consumer and developer tools including the A1C Insights mobile application, the Sally Console developer platform, an MCP server, and machine learning models published on Hugging Face. The token is designed to function as a utility mechanism linked to platform features and AI service subscriptions.

    Governance and operations are entirely centralized under A1C PTE. LTD., with no decentralized autonomous organization (DAO), token-holder voting mechanisms, or on-chain governance processes. The project's leadership and development team remain completely anonymous, with no publicly disclosed founders, executives, or verifiable professional backgrounds. Additionally, supply data shows substantial discrepancies across market aggregators, with some providers reporting a 21 million total and circulating supply while others list a 100 million total supply with 75 million circulating tokens, alongside an absence of published vesting schedules or token allocation breakdowns.

    From a security standpoint, the smart contract has not undergone an independent third-party audit by a recognized security firm, and no verified security ratings exist for the project. While no hacks, exploits, depegs, or regulatory actions have been documented, the project is characterized by severe liquidity fragmentation, conflicting market valuations across data aggregators, and a thin public community footprint largely limited to decentralized trading on Uniswap V2.

    Similar Rated Tokens